Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Twist Bioscience Announces The Expansion Of Its DNA Synthesis Offering With The Launch Of Gene Fragments With Increased Lengths Ranging From 1.8kb To 5.0kb

Author: Benzinga Newsdesk | August 08, 2024 08:37am

Industry leading product available through Twist ecommerce platform

Twist Gene Fragments now available up to 5.0kb in length with the same speed, quality, and affordability as shorter fragments

Turnaround time starting at two business days

Twist Bioscience Corporation (NASDAQ:TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the expansion of its DNA synthesis offering with the launch of Gene Fragments with increased lengths ranging from 1.8kb to 5.0kb.

Posted In: TWST

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist